BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 21487766)

  • 1. Dyslipidemia in children with CKD: should we treat with statins?
    Tullus K
    Pediatr Nephrol; 2012 Mar; 27(3):357-62. PubMed ID: 21487766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin treatment for dyslipidemia in chronic kidney disease and renal transplantation: a review of the evidence.
    Kanbay M; Turgut F; Covic A; Goldsmith D
    J Nephrol; 2009; 22(5):598-609. PubMed ID: 19809992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Statins in patients with kidney failure: efficacy, tolerance, and prescription guidelines in patients with chronic kidney disease and renal transplant].
    Karie S; Launay-Vacher V; Deray G; Isnard-Bagnis C
    Presse Med; 2006 Feb; 35(2 Pt 1):219-29. PubMed ID: 16493350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of statins on renal function.
    Agarwal R
    Mayo Clin Proc; 2007 Nov; 82(11):1381-90. PubMed ID: 17976359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyslipidemia in chronic kidney disease: are statins still indicated in reduction cardiovascular risk in patients on dialysis treatment?
    Scarpioni R; Ricardi M; Melfa L; Cristinelli L
    Cardiovasc Ther; 2010 Dec; 28(6):361-8. PubMed ID: 20553296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyslipidemia, statins, and CKD patients' outcomes - review of the evidence in the post-sharp era.
    Heymann EP; Kassimatis TI; Goldsmith DJ
    J Nephrol; 2012; 25(4):460-72. PubMed ID: 22641572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic kidney disease and statins: improving cardiovascular outcomes.
    Walker DB; Walker TJ; Jacobson TA
    Curr Atheroscler Rep; 2009 Jul; 11(4):301-8. PubMed ID: 19500494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic kidney disease and statins].
    Matovinović MS
    Lijec Vjesn; 2006; 128(11-12):345-50. PubMed ID: 17212196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is lipid management effective for all stages of CKD?
    Ku E; Campese V
    Blood Purif; 2013; 35(1-3):26-30. PubMed ID: 23343543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular disease in patients with renal disease: the role of statins.
    Fellström B; Holdaas H; Jardine AG; Svensson MK; Gottlow M; Schmieder RE; Zannad F;
    Curr Med Res Opin; 2009 Jan; 25(1):271-85. PubMed ID: 19210158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid management in chronic kidney disease, hemodialysis, and transplantation.
    Montague T; Murphy B
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):223-34. PubMed ID: 19217521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyslipidemia in patients with chronic kidney disease.
    Hager MR; Narla AD; Tannock LR
    Rev Endocr Metab Disord; 2017 Mar; 18(1):29-40. PubMed ID: 28000009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins for treatment of dyslipidemia in chronic kidney disease.
    Shurraw S; Tonelli M
    Perit Dial Int; 2006; 26(5):523-39. PubMed ID: 16973506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Statins: what is their place in the treatment of chronic kidney insufficiency?].
    Ponte B; Bourquin V; Stoermann-Chopard C
    Rev Med Suisse; 2009 Feb; 5(192):463-4, 466-8. PubMed ID: 19317313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins and renal disease: friend or foe?
    Deshmukh A; Mehta JL
    Curr Atheroscler Rep; 2011 Feb; 13(1):57-63. PubMed ID: 21053107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyslipidemia in Patients with Kidney Disease.
    Thobani A; Jacobson TA
    Cardiol Clin; 2021 Aug; 39(3):353-363. PubMed ID: 34247749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should we use statins in all patients with chronic kidney disease without dialysis therapy? The current state of knowledge.
    Rysz J; Gluba-Brzózka A; Banach M; Więcek A
    Int Urol Nephrol; 2015 May; 47(5):805-13. PubMed ID: 25758011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Navaneethan SD; Pansini F; Perkovic V; Manno C; Pellegrini F; Johnson DW; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2009 Apr; (2):CD007784. PubMed ID: 19370693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dyslipidemia, malnutrition, inflammation, cardiovascular disease and mortality in chronic kidney disease.
    Peev V; Nayer A; Contreras G
    Curr Opin Lipidol; 2014 Feb; 25(1):54-60. PubMed ID: 24345987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.